COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 420: Articles 4191-4200  | Next

Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression as a Risk-Factor for SARS-CoV-2 Transmission in Concurrent Hospital Associated Outbreaks
Nikiforuk, A. M., Kuchinski, K. S., Short, K., Roman, S., Irvine, M. A., Prystajecky, N., Jassem, A. N., Patrick, D. M., Sekirov, I.
10.1101/2023.03.20.23287264 — Posted: 2023-03-21
Endemic-epidemic modelling of school closure to prevent spread of COVID-19 in Switzerland
Bekker-Nielsen Dunbar, M., Hofmann, F., Meyer, S., Held, L.
10.1101/2023.03.21.23287519 — Posted: 2023-03-21
SARS-CoV-2 infection activates endogenous retroviruses of the LTR69 subfamily
Arora, A., Kolberg, J. E., Badarinarayan, S. S., Munot, D., Mueller, M., Sauter, D., Bansal, V.
10.1101/2023.03.21.533610 — Posted: 2023-03-21
SARS-CoV-2 infection induces dopaminergic neuronal loss in midbrain organoids during short and prolonged cultures
Jarazo, J., Santos da Silva, E., Glaab, E., Perez-Bercoff, D., Schwamborn, J. C.
10.1101/2023.03.20.533485 — Posted: 2023-03-21
Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron Variants.
Cacciottolo, M., Li, Y., Nice, J. B., LeClaire, M. J., Twaddle, R., Mora, C. L., Adachi, S. Y., Young, M., Angeles, J., Elliott, K., Sun, M.
10.1101/2023.03.20.533560 — Posted: 2023-03-21
Defining drivers of under-immunisation and vaccine hesitancy in refugee and migrant populations globally to support strategies to strengthen vaccine uptake for COVID-19: a rapid review
Deal, A., Crawshaw, A. F., Carter, J., Knights, F., Iwami, M., Darwish, M., Hossain, R., Immordino, P., Kaojaroen, K., Severoni, S., Hargreaves, S.
10.1101/2023.03.20.23287477 — Posted: 2023-03-20
Antibiotic prescribing in remote versus face-to-face consultations for acute respiratory infections in English primary care: An observational study using TMLE
Vestesson, E., De Corte, K. L. A., Chappell, P., Crellin, E., Clarke, G. M.
10.1101/2023.03.20.23287466 — Posted: 2023-03-20
New Approach to the SIR Inversion Problem: From the 1905-1906 Plague Outbreak in the Isle of Bombay to the 2021-2022 Omicron Surges in New York City and Los Angeles County
Harris, J. E.
10.1101/2023.03.13.23287177 — Posted: 2023-03-20
Childhood Adversity and COVID-19 Outcomes: Findings from the UK Biobank
Hanson, J. L., O'Connor, K. A., Adkins, D. J., Kahhale, I.
10.1101/2023.03.20.23287479 — Posted: 2023-03-20
Safety and Effectiveness of SA58 Nasal Spray against SARS-CoV-2 family transmission: an exploratory single-arm trial
Wang, L., Song, R., Hu, Y., Zeng, G., Sun, K., Wang, J., Bao, Y., Zhou, Y., Cheng, L., Wu, C., Pu, J., Han, X., Wu, J., Jin, R., Gao, Q.
10.1101/2023.03.19.23287462 — Posted: 2023-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).